IL6 Human, Sf9

Interleukin-6 Human Recombinant, Sf9
Shipped with Ice Packs
In Stock

Description

Key Molecular Features

ParameterValue/DescriptionSource
Amino Acid Sequence189 residues (30–212aa)
Molecular Weight21.6 kDa (migrates 18–28 kDa on SDS-PAGE due to glycosylation)
Post-Translational ModificationsGlycosylation (crucial for folding and activity)
Tag6xHis-tag at C-terminus for purification
Formulation0.5 mg/ml in PBS (pH 7.4) + 10% glycerol

Production Process in Sf9 Cells

IL6 Human, Sf9 is synthesized through a baculovirus expression system:

  1. Cloning: Human IL-6 gene is inserted into a baculovirus transfer vector.

  2. Transfection: Linearized baculovirus DNA and transfer vector are introduced into Sf9 cells.

  3. Virus Amplification: Recombinant baculovirus is propagated in Sf9 cultures.

  4. Protein Secretion: IL-6 is expressed and secreted into the medium.

  5. Purification: Chromatographic techniques isolate the His-tagged protein.

Advantages Over E. coli Systems

SystemSf9 CellsE. coli
GlycosylationNative-like post-translational modificationsAbsent (non-glycosylated)
FoldingProper tertiary structureOften misfolded
ActivityFull biological functionalityReduced (e.g., CYT-213 in )

Biological Properties and Functional Roles

IL6 Human, Sf9 exhibits pleiotropic effects:

Immune Regulation

  • B Cell Differentiation: Induces plasma cell formation and immunoglobulin secretion .

  • T Cell Activation: Drives Th17 polarization and inhibits Th1 responses via STAT3/SOCS3 pathways .

  • Hematopoiesis: Supports myeloma/plasmacytoma growth .

Inflammation and Viral Responses

  • Antiviral Activity: Suppresses hepatitis B virus (HBV) replication by blocking receptor expression (NTCP) .

  • Immunosuppressive Effects: Excess IL-6 impairs CD8+ T-cell cytotoxicity (via SOCS3-mediated inhibition of STAT4) .

Experimental Uses

ApplicationExampleSource
Cytokine Signaling StudiesInvestigating IL-6Rα/IL-6ST interactions in trans-signaling
Viral Pathogenesis ModelsStudying IL-6’s dual role in HBV suppression and immune evasion
Cancer ResearchEvaluating IL-6-driven myeloma/plasmacytoma growth

Therapeutic Potential

  • Autoimmune Diseases: Targeting IL-6 trans-signaling with sgp130Fc to mitigate inflammation .

  • Hematopoietic Disorders: Leveraging IL-6’s role in stem cell self-renewal .

Production Challenges

IssueSolution
Low YieldBaculovirus titer optimization; media formulation refinement
Protease DegradationInclusion of protease inhibitors; rapid purification post-harvest

Comparative Analysis: IL6 Human, Sf9 vs. Mouse IL6, Sf9

PropertyIL6 Human, Sf9IL6 Mouse, Sf9
Amino Acids189 (30–212aa)193 (25–211aa)
Molecular Weight21.6 kDa22.5 kDa
Biological ActivityED₅₀ ≤ 0.1 ng/ml (human B cells)ED₅₀ ≤ 0.1 ng/ml (mouse M-NFS-60 cells)
ApplicationsHuman immune studies, HBV models Mouse immunology, viral pathogenesis

Viral Infections

  • HBV: IL6 Human, Sf9 inhibits viral entry by downregulating NTCP .

  • HIV: Elevated IL-6 correlates with residual viremia and T-cell dysfunction .

Inflammatory Diseases

  • Rheumatoid Arthritis: IL-6 overexpression drives synovial inflammation .

  • COVID-19: Hyperinflammatory states linked to IL-6 dysregulation .

Product Specs

Introduction
Interleukin-6, also known as IL-6, is a multifunctional cytokine with a wide range of biological effects. It plays a vital role in the final differentiation of B cells into antibody-secreting cells. IL-6 is also known to promote the growth of myeloma and plasmacytoma cells. Furthermore, it induces the differentiation of nerve cells and stimulates the production of acute-phase reactants in hepatocytes.
Description
Recombinant Human IL6, produced in Baculovirus, is a single glycosylated polypeptide chain comprising 189 amino acids (30-212aa). It has a molecular mass of 21.6 kDa and appears between 18-28 kDa on SDS-PAGE under reducing conditions. The IL6 protein is fused to a 6 amino acid His-Tag at the C-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The IL6 protein solution is provided at a concentration of 0.5 mg/ml in Phosphate Buffered Saline (pH 7.4) containing 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), store the vial at 4°C. For extended storage, freeze the solution at -20°C. Adding a carrier protein like HSA or BSA (0.1%) is recommended for long-term storage. Avoid repeated freeze-thaw cycles to maintain protein integrity.
Purity
The purity of IL6 protein is greater than 95.0%, as determined by SDS-PAGE analysis.
Biological Activity
The biological activity of IL6 is measured using a cell proliferation assay with TF-1 human erythroleukemic cells. The ED50, which represents the concentration required for half-maximal response, is in the range of 0.2 - 0.8 ng/ml.
Synonyms

BSF2, HGF, HSF, IFNB2, IL-6.

Source
Sf9, Baculovirus cells.
Amino Acid Sequence

VPPGEDSKDV AAPHRQPLTS SERIDKQIRY ILDGISALRK ETCNKSNMCE SSKEALAENN
LNLPKMAEKD GCFQSGFNEE TCLVKIITGL LEFEVYLEYL QNRFESSEEQ ARAVQMSTKV
LIQFLQKKAK NLDAITTPDP TTNASLLTKL QAQNQWLQDM TTHLILRSFK EFLQSSLRAL RQMHHHHHH.

Product Science Overview

Introduction

Interleukin-6 (IL-6) is a multifunctional cytokine that plays a crucial role in immune regulation, inflammation, and hematopoiesis. It is involved in various physiological processes, including the differentiation of B-cells into immunoglobulin-secreting cells, the growth of myeloma and plasmacytoma cells, and the induction of acute phase reactants in hepatocytes .

Production of Human Recombinant IL-6

Human Recombinant IL-6 is produced using the Sf9 insect cell system, which is derived from the Spodoptera frugiperda (fall armyworm). This system utilizes baculovirus vectors to efficiently express recombinant proteins. The production process involves cloning the human IL-6 gene into a baculovirus transfer vector, which is then co-transfected with linearized baculovirus DNA into Sf9 cells .

Characteristics of Human Recombinant IL-6

The recombinant IL-6 produced in Sf9 cells is a single glycosylated polypeptide chain containing 189 amino acids, with a molecular mass of approximately 21.6 kDa. It is fused to a 6 amino acid His-Tag at the C-terminus and purified using proprietary chromatographic techniques. The protein is typically formulated in a phosphate-buffered saline (PBS) solution with 10% glycerol for stability .

Biological Activity

Human Recombinant IL-6 exhibits significant biological activity. It has been shown to induce the proliferation of TF-1 human erythroleukemic cells, with an effective dose (ED50) ranging from 0.2 to 0.8 ng/mL . This activity underscores its importance in various biological processes and its potential therapeutic applications.

Applications and Significance

The production of Human Recombinant IL-6 using the Sf9 cell system provides a versatile tool for investigating its biological functions and potential therapeutic applications. IL-6 is a target of intensive research due to its pivotal role in immune regulation and inflammation. Understanding its mechanisms can lead to the development of novel therapeutic strategies for various diseases, including autoimmune disorders, cancers, and inflammatory conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.